Device Week, 13 August 2021 – TriGuard 3 FDA Panel Meeting , Experts Talk QS Reg

In this week’s podcast, we take a look at the concerns a US FDA advisory panel recently expressed about Keystone Heart’s TriGUARD 3, then discuss some expert predictions on the FDA’s hotly anticipated Quality System Regulations (QSR) rewrite.